- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Snapshot for Celsion Corp (CLSN)
| Open: | 1.2000 | Day's Range: | 1.1700 - 1.3400 | Volume: | 2,751,046 |
|---|---|---|---|---|---|
| Previous Close: | 1.2100 | 52wk Range: | 0.7500 - 9.4400 | 1-Yr Rtn: | -38.79% |
Key Statistics for CLSN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.5800 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 74.80 |
| Shares Outstanding (M) | 57.10 |
| 30 Day Average Volume | 8,485,610 |
| Price/Book (mrq) | 2.0617 |
| Price/Sale (ttm) | 450.5981 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CLSN
Company Profile & Key Executives for CLSN
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
| Michael H TardugnoPresident/CEO | Gregory G Weaver "Greg"Senior VP/CFO |
| Jeffrey W Church "Jeff"Senior VP:Strategy/Secretary | Nicholas BorysVP/Chief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CLSN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page